DI LENARDA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 9.801
NA - Nord America 8.111
AS - Asia 4.013
SA - Sud America 535
AF - Africa 128
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.615
Nazione #
US - Stati Uniti d'America 7.951
RU - Federazione Russa 3.333
IT - Italia 2.730
PL - Polonia 1.537
SG - Singapore 1.462
CN - Cina 879
SE - Svezia 430
BR - Brasile 408
VN - Vietnam 397
DE - Germania 395
HK - Hong Kong 379
FR - Francia 241
UA - Ucraina 204
NL - Olanda 190
BD - Bangladesh 183
GB - Regno Unito 173
TR - Turchia 156
FI - Finlandia 152
KR - Corea 145
IN - India 102
BG - Bulgaria 91
IE - Irlanda 85
CA - Canada 78
JP - Giappone 73
ES - Italia 49
MX - Messico 45
AR - Argentina 40
BE - Belgio 37
MA - Marocco 36
CH - Svizzera 33
IQ - Iraq 24
PK - Pakistan 24
ID - Indonesia 23
AU - Australia 22
CO - Colombia 22
AT - Austria 21
TG - Togo 20
IR - Iran 18
ZA - Sudafrica 18
EC - Ecuador 17
RO - Romania 17
KZ - Kazakistan 16
PH - Filippine 14
TW - Taiwan 14
PY - Paraguay 13
SA - Arabia Saudita 13
SN - Senegal 13
TH - Thailandia 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
PE - Perù 11
DK - Danimarca 10
JO - Giordania 10
MY - Malesia 10
VE - Venezuela 10
DZ - Algeria 9
KE - Kenya 9
CL - Cile 8
HR - Croazia 8
LT - Lituania 8
CR - Costa Rica 7
IL - Israele 7
PT - Portogallo 7
UZ - Uzbekistan 6
AZ - Azerbaigian 5
HU - Ungheria 5
KG - Kirghizistan 5
NO - Norvegia 5
NP - Nepal 5
EG - Egitto 4
EU - Europa 4
HN - Honduras 4
JM - Giamaica 4
LV - Lettonia 4
OM - Oman 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
EE - Estonia 3
ET - Etiopia 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GG - Guernsey 2
GR - Grecia 2
GT - Guatemala 2
MK - Macedonia 2
SI - Slovenia 2
TN - Tunisia 2
AO - Angola 1
Totale 22.591
Città #
Moscow 3.234
Warsaw 1.460
Ashburn 948
Singapore 913
Fairfield 739
Houston 650
Chandler 536
Woodbridge 511
San Jose 474
Hong Kong 367
Wilmington 353
Ann Arbor 346
Seattle 325
Cambridge 274
Milan 261
Trieste 233
Jacksonville 219
Beijing 218
Rome 193
Seoul 141
Princeton 139
Boardman 119
Ho Chi Minh City 112
Los Angeles 112
Chicago 106
Hefei 101
Izmir 99
Santa Clara 95
Lauterbourg 86
Sofia 86
Dearborn 84
Dublin 82
New York 78
Columbus 77
Hanoi 73
Helsinki 70
Council Bluffs 68
Frankfurt am Main 65
The Dalles 64
Zgierz 64
Munich 62
London 55
Naples 48
São Paulo 48
Turin 48
Buffalo 45
Dallas 44
Düsseldorf 44
Tokyo 42
San Diego 41
Bari 39
Bologna 39
Florence 31
Guangzhou 31
Brussels 30
Casablanca 29
Padova 29
Bremen 27
Grafing 27
Des Moines 26
Denver 25
Nuremberg 25
Redondo Beach 25
Falls Church 24
Phoenix 24
Shanghai 24
Turku 24
Nanjing 23
Orem 23
Venice 23
Genoa 21
Palermo 21
Redwood City 21
Toronto 21
Cagliari 20
Dong Ket 20
Kocaeli 20
Lomé 20
Verona 20
Montreal 19
Udine 19
Catania 18
Jinan 18
Pune 18
Atlanta 17
Chennai 17
Madrid 17
Stockholm 17
Amsterdam 16
Brescia 16
Brooklyn 16
Modena 16
Ankara 15
Haiphong 15
Norwalk 15
Tianjin 15
Johannesburg 14
Kunming 14
Mexico City 14
Bern 13
Totale 15.723
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 3.335
Continuità assistenziale ospedale-territorio per il paziente con scompenso cardiaco cronico: Una rivoluzione e una sfida nella cura ambulatoriale 1.158
Documento di consenso ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: Il percorso clinico-diagnostico e terapeutico del paziente con scompenso cardiaco acuto dal domicilio alla dimissione dal Pronto Soccorso/ Dipartimento di Emergenza-Accettazione 837
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study 455
Should we fear direct oral anticoagulants more than vitamin K antagonists in simple single tooth extraction? A prospective comparative study 436
Natural History of Dilated Cardiomyopathy in Children 434
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 427
Role of Titin Missense Variants in Dilated Cardiomyopathy 422
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 408
Gingival overgrowth caused by Olmesartan Medoxomil: Observational study 377
Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography 370
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 366
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 361
Multi-state modelling of heart failure care path: A population-based investigation from Italy 360
La fibrillazione atriale non valvolare: dati dall’Osservatorio delle Malattie Cardiovascolari della provincia di Trieste [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)] 332
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 327
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 324
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 297
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 295
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 280
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 273
A new integrated approach to cardiac mechanics: reference values for normal left ventricle 267
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 256
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 255
Incremental Value of Gait Speed in Predicting Prognosis of Older Adults With Heart Failure. Insights From the IMAGE-HF Study 254
Prognostic role of cardiac calcifications in primary prevention: A powerful marker of adverse outcome highly dependent on underlying cardiac rhythm 246
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study 243
Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria. 239
Systolic blood pressure target in systemic arterial hypertension: Is lower ever better? Results from a community-based Caucasian cohort 239
Personalized support for chronic conditions. A novel approach for enhancing self-management and improving lifestyle. 235
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 228
Il raggiungimento dei target raccomandati di profilo lipidico in una popolazione con cardiopatia ischemica cronica: dalle linee guida al mondo reale 223
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 221
Administrative database, observational research and the Tower of Babel 220
Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: The "EPIDAURO registry" 214
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 210
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Asymptomatic Aortic Stenosis 209
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 206
Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure 205
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: Data from the MECKI Score Research Group 201
Cardiomiopatie 2008. Una riflessione a proposito delle recenti classificazioni dell'American Heart Association e del Working Group on Myocardial and Pericardial Diseases della Società Europea di Cardiologia 198
Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease 196
Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patients 195
Insights from Cardiac Mechanics after Three Decades from Successfully Repaired Aortic Coarctation 193
HF progression among outpatients with HF in a community setting 193
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 193
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 191
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 189
Chronic kidney disease and prognosis in elderly patients with cardiovascular disease: Comparison between CKD-EPI and Berlin Initiative Study-1 formulas 185
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 183
Three dimensional printing of an atrial septal defect: Is it multimodality imaging? 182
Uno sguardo allo scompenso cardiaco con frazione di eiezione preservata: dai trial al mondo reale dell’Osservatorio Cardiovascolare del Friuli-Venezia Giulia 176
SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. 175
Response to: “Direct oral anticoagulants, vitamin K antagonists and simple single tooth extraction” 175
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 175
Comparison of discrimination and calibration performance of ECG-based machine learning models for prediction of new-onset atrial fibrillation 170
Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. 170
Left ventricular function and exercise performance in idiopathic dilated cardiomyopathy: Role of tissue Doppler imaging 169
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 169
Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. 167
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 166
Impact of left ventricular hemodynamic forces in adult patients with treated aortic coarctation and preserved left ventricular systolic function 163
Diagnosi e cura dell’amiloidosi cardiaca in Italia: risultati della survey della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 161
[Disease management system in patients with chronic heart failure] 161
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. 158
Managing heart failure in the very old 154
Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records 145
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease 143
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 142
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 139
Heart failure and anemia: Effects on prognostic variables 136
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 132
The hemodynamic power of the heart differentiates normal from diseased right ventricles 132
Sex-related differences in chronic heart failure: a community-based study 127
Wavelet‐Mixed Landmark Survival Models for the Effect of Short‐Term Changes of Potassium in Heart Failure Patients 127
Impact of Atrial Fibrillation on Outcome of Patients with Idiopathic Dilated Cardiomyopathy: Data from the Heart Muscle Disease Registry of Trieste 122
Heart failure patients with improved ejection fraction: insights from the MECKI Score database 118
Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study 104
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population) 99
Is L-PRF an effective hemostatic agent in single tooth extractions? A cohort study on VKA and DOAC patients 96
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the MECKI score data-set 96
Tissue Doppler indices of diastolic function as prognosticator in patients without heart failure in primary care 87
Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors 85
LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience 78
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 60
Optimising Return to Work for Cardiovascular Patients: An Interdisciplinary Approach in Occupational Medicine and Cardiology 41
Management of Idiopathic Recurrent Pericarditis in Adults and in Children: A Role for IL-1 Receptor Antagonism 35
Totale 23.096
Categoria #
all - tutte 54.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 0 122
2021/20221.281 57 87 67 78 86 132 68 67 142 120 89 288
2022/20231.867 147 205 137 250 177 293 56 168 198 49 126 61
2023/20242.257 106 115 85 99 126 150 233 159 35 176 633 340
2024/20254.954 799 870 549 680 284 233 165 164 307 381 254 268
2025/20266.041 547 285 342 490 524 459 877 305 731 871 350 260
Totale 23.096